Predicting population coverage of T-cell epitope-based diagnostics and vaccines

Area of Science:

• Immunology
• Computational Biology
• Vaccinology

Background:

• T cells recognize pathogen epitopes bound to Major Histocompatibility Complex (MHC) molecules.
• Human Leukocyte Antigen (HLA) alleles, the human MHC, are highly polymorphic, influencing epitope binding specificity.
• Differential HLA allele frequencies across ethnicities can lead to biased population coverage in epitope-based medical interventions.

Purpose of the Study:

• To develop a method for predicting the population coverage of epitope-based diagnostics and vaccines.
• To address the challenge of ethnic bias in vaccine and diagnostic design due to HLA polymorphism.
• To create a tool that maximizes population coverage while minimizing complexity and ethnic variability.

Main Methods:

• An algorithm was developed to calculate expected immune response fractions based on HLA genotypic frequencies.
• Population coverage estimates utilize MHC binding and/or T cell restriction data.
• The algorithm was implemented as a publicly accessible web application.

Main Results:

• A web-based tool was created to predict the population coverage of T-cell epitope-based diagnostics and vaccines.
• The tool calculates the fraction of individuals likely to respond to specific epitope sets.
• Estimates are based on HLA genotypic frequencies and MHC binding/T cell restriction data.

Conclusions:

• A web-based tool enables prediction of population coverage for T-cell epitope-based interventions.
• Epitope-based vaccines and diagnostics can be designed for maximized and equitable population coverage.
• The tool aids in minimizing the number of epitopes and variability in coverage across ethnic groups.